Worldwide Healthcare M&A totals $649.4 billion, more than the previous two full years combined.
Worldwide Pharma M&A totals $415.6 billion, more than the previous three full years combined.
The Pfizer/Allergan combination ranks as the second largest M&A transaction on record, behind Vodafone Airtouch’s $202.8 billion acquisition of Mannesmann in 1999.
Pfizer holds the top two spots on the all-time Pharma list with today’s combination and the $88.8 billion acquisition of Warner-Lambert in 1999.
Six of the top 20 all-time Pharma deals involve Pfizer.
Since records began in 1980, just six deals have surpassed the $100 billion mark, two announced this year. Today’s Pfizer/Allergan deal is the fourth deal announced so far this year to join the all-time Top 20.